RXAIPO Pharma, AI, Public Opportunities

This episode is also available as a blog post: http://mihirotia.data.blog/2022/07/31/ai-in-biotech-the-upgrade-to-biotechnology-and-neuroscience/

This episode is also available as a blog post: http://mihirotia.data.blog/2022/07/07/ai-gastroenterology-what-impact-does-ai-leave-on-this-nascent-field/

This episode is also available as a blog post: http://mihirotia.data.blog/2022/05/31/ai-in-health-care-how-ai-is-transforming-the-future-for-doctors-and-patients-diagnostics/

This episode is also available as a blog post: http://mihirotia.data.blog/2022/04/06/blockchain-revolutionising-the-pharmaceutical-industry/

This episode is also available as a blog post: http://mihirotia.data.blog/2022/03/01/pharma-analytics-the-new-trend-for-business-analytics-and-its-roots-in-pharma-and-ai-business/

This episode is also available as a blog post: http://mihirotia.data.blog/2022/02/06/ai-the-asset-for-digital-marketing-and-pharmacy/

This episode is also available as a blog post: http://mihirotia.data.blog/2022/01/15/synergism-of-ai-amp-neuroscience/

This episode is also available as a blog post: http://mihirotia.data.blog/2021/11/11/how-sensual-is-ai/

This episode is also available as a blog post: http://mihirotia.data.blog/2021/10/03/ai-in-cardiology-now-prospects/

This episode is also available as a blog post: http://mihirotia.data.blog/2021/09/13/needle-less-immunization/